Drug Profile
Topotecan - Hospira
Alternative Names: Onco-TainLatest Information Update: 03 Nov 2021
Price :
$50
*
At a glance
- Originator Hospira
- Class Antineoplastics; Camptothecins; Small molecules
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Small cell lung cancer
- Registered Cervical cancer
Most Recent Events
- 12 Feb 2019 Topotecan is not yet available for Cervical cancer and Small cell lung cancer in the European Union, Iceland, Norway and Liechtenstein
- 03 Sep 2015 Hospira has been acquired by Pfizer